This resource captures Oregon Health & Science University’s practice recommendations for the management of pain in patients on buprenorphine undergoing surgery and pregnant women during labor, delivery, and the post-partum period. The guidelines were developed through an evidence review of the harms and benefits of continuing buprenorphine treatment during these clinical episodes. and the clinical expertise and consensus of the guideline committee. The committee issued a strong recommendation for continuing buprenorphine but noted the very low strength of evidence available to guide decisions. This policy was included as one of the protocols and tools for Oregon Health & Science University’s Improving Addiction Care Team (IMPACT) program which provides addiction medicine consultations to patients treated in the hospital who have a diagnosis of substance use disorder.
Funding Source: Oregon Health & Science University
Improving Addiction Care Team (IMPACT): OHSU Practice Recommendations for the Perioperative Management of Patients on Buprenorphine-Containing Drugs
The Oregon Health & Science University practice recommendations for the management of pain in patients on buprenorphine undergoing surgery and pregnant women during labor, delivery, and the post-partum period